Noticeboard

The Lalji Family ALS Award is accepting nominations for individual or team of investigators who have made significant progress impacting the repair and regeneration of neuronal degeneration that may be applied in ALS.

This is a global award celebrating excellence in research for an individual or team of investigators who are making transformative breakthroughs in the science of repair and regeneration of neurological function.

The award will be presented at the International Symposium on ALS/MND in Amsterdam on the 9-11 December 2026. The selected nominee will be awarded $40,000 USD.

Prize Criteria

• Applicant must have an MD, PhD or equivalent degree and be a leader in the field of ALS or regenerative medicine/biology with a strong publication record.
• The proposal must have a strong scientific rationale with a focus on repair of neurological function.
• Inclusion of preliminary findings demonstrating approach and feasibility in pre-clinical models is recommended.
• International applicants are encouraged to apply.

Application deadline: 3 September

Find out more and apply

The award is granted annually to young researchers that investigate issues associated with ALS, particularly those dealing with the causes and treatment of this disease. Candidates must have relevant publications in scientific journals within the two-year period preceding the application.

The award will be presented at the International Symposium on ALS/MND in Amsterdam in December.

Deadline for application: 13 September 

Find out more and apply

The Radala Foundation is looking for established, leading principal investigators eligible for 200,000 CHF (~£181,500 GBP) research funding to pursue a potentially ground-breaking, high-risk project for 2 years in basic research in ALS.

Principal Investigators (PI) are expected to be active researchers who have a track-record of significant research achievements in the last 5 years. Investigators active in ALS research or in broadly related fields are encouraged to submit proposals relevant to ALS. Research must be conducted in a public or private research organisation (known as a host institution).

The goal of the Radala foundation is to provide research grants for the study of the understanding of the basic causes of the disease. These awards are not directed to clinically related projects for patient care. There is no geographical limitation to the recipients of these grants. 

Application deadline: 30 September

Find out more and apply

The 7th UCL Queen Square Motor Neuron Disease Centre International Symposium will be held in person at Queen Square in London on Friday 11th September 2026 from 09:30am to 5:40pm (GMT).

The programme includes talks on a range of topics from clincial trial updates to the development of new gene therapies and new targets for therapies in the future. 

Registration is free.

Find out more and register

Hosted by St Christopher’s and King’s MND Care and Research Centre, this popular annual one day conference will focus on topics including  clinical trials, psychological support, and communication technology. The conference brings together together healthcare professionals, researchers and people with lived experience to share knowledge, explore challenges and strengthen care for people living with MND.

The conference is aimed at healthcare professionals involved in the care of people with MND.

This meeting is taking place on the 6 November at St Christopher's CARE in London and online.

Find out more and register
 

The 2026 Annual Stephen Hawking MND Lecture will focus on the topic of technology enhancing care in MND and be delivered by Dr Esther Hobson.

The session will explore the role of technology in MND care and research, including:

understanding of how specialist technologies can enhance MND care and support research

an overview of current and emerging technologies

how to identify, assess and match appropriate technologies to individual needs and goals

The lecture is open to health and social care professionals.

It is a hybrid event, taking place on the 17 November at the Royal Society of Medicine in London and online.

Find out more and register

The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the MND Association’s rationale behind the creation of the International Symposium on ALS/MND.

Each year, the Symposium attracts over 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management. 

The 37th Symposium will be held in Amsterdam in the Netherlands from the 9-11 December 2026.

Find out more

For many neurodegenerative diseases the current treatments only address the symptoms and not disease progression, whilst these treatments can be very helpful there is an urgent need for disease modifying therapies.  Over the last few years we have seen significant advances in our understanding of the underlying biology, identification of new therapeutic targets and the design of novel drug candidates.  This meeting will highlight leading research in the design and development of new therapeutics.

This event will take place on the 5 to 6 April at the Wellcome Genome Campus in Cambridgeshire.

Deadline for oral abstract submission Monday 14 December.
Deadline for poster abstract submission Monday 1 February.

Find out more and apply